MECOR Turkey 2015--Çeşme
Merhaba Çeşme!
MECOR Türkiye 2015
Liderlerimiz
Dr. Fusun Öner EYÜBOĞLU,
MECOR Turkey Kurs Direktörü
Dr. A. Sonia Buist,
ATS MECOR Program Sorumlusu
Dr. Arzu Yorgancıoglu,
Türk Toraks Derneği Başkanı
MECOR Türkiye 2015
Açılış
MECOR Türkiye 2015
Kurs Katılımcılarımız—Level 1
You won’t admit you love me And so how am I ever to know? You only tell me MECOR, MECOR, MECOR Defalarca sordum sana neden? Cevap vermein içten HHekese bahset MECOR, MECOR, MECOR If you can’t make up your mind We’ll never get started And I don’t wanna wind up Being parted, broken hearted Beni gerçekten sevdiysen söyle Asla hayir deme Herkese bahset MECOR, MECOR, MECOR Beni gerçekten sevdiysen söyle Asla hayir deme Herkese bahset MECOR, MECOR, MECOR MECOR TÜrkiye 2015
Level 1
MECOR Türkiye 2015
Level 1
MECOR Türkiye 2015
Level 1
MECOR Turkey 2015
Level 1
MECOR Türkiye 2015
Level 2
"MammaMECOR"
I'vebeenplanningastudysinceIdon't
knowwhen,
Itwasbadlydesignedsoitcametoan
end,
Lookatmenow,willIeverlearn?
Idon'tknowhowbutIsuddenly
understand
NowIhaveagoodstudyplan
Justonelook,Icanseeconfounding
Onemorelook,Iadjust(for)everything,
w‐o‐o‐o‐oh
MammaMECOR,hereIgoagain
Mymy,howcanIimpressyou?
MammaMECOR,doesitshowagain?
Mymy,SoniahowI'veneededyou
Yes,I'vebeensofrustrated
I’mfeelingsaturated
Why,whydidIeverletyougo?
MammaMECOR,nowIreallyknow,
Mymy,Icouldneverletyougo.
(sungtoAbba,MammaMia!)
MECOR Türkiye 2015
Level 2
MECOR Türkiye 2015
Level 2
MECOR Türkiye 2015
Level 2
MECOR Türkiye 2015
Level 3
Crazy Little Thing MECOR
This thing MECOR I just can’t handle it This thing MEOCR I must get around it I ain’t ready Crazy little thing MECOR This thing MECOR I cry (like a baby) In a sleepless night It swings (Woo Woo) Beta (Woo Woo) It all depends on your sample size I kinda like it Crazy little thing MECOR There goes Mama MECOR She how to Rock n’roll She drives us crazy Keep it simple stupid She tells us to write a MOP, MOP, MOP Be cool, relax, get hip Get on my stats Garbage in, garbage out Take a long ride in Level 3 I’m ready Crazy little thing MECOR Be cool, relax, get hip, Get on my stats How rare? P‐value rare! Take a long ride in Level 3 I ready (ready Freddie) Crazy little thing MECOR This thing MECOR, I just can’t handle it This thing MECOR, I must get around it I ain’t ready Crazy little thing MECOR MECOR Türkiye 2015
Level 3
MECOR Türkiye 2015
Level 3
MECOR 2015
The Global Course
MECOR 2015
The Global Course
MECOR 2015
The Global Course
MECOR 2015
The Global Course
MECOR Türkiye 2015
Our Faculty
MECORTime
Oh,Oh,Oh
MECORMECORTIME
OH,OH,OH
MECORMECORTIME
Ifyousaidgoodbyetometonight
Therewouldstillbepaperslefttowrite
WhatelsecouldIdo?
I’vegotmanyquestionsforyou
Iwon’tbesleepingforthelongesttime
OnceIthoughtmystudywasokay
NowIknowthatImadeahugemistake
Becauseyoutoldme,thatIneed2000patients
ThatstudyendedafterMECORTIME!
Oh,Oh,Oh
MECORMECORTIME
OH,OH,OH
MECORMECORTIME
Imightnothavealicensetoregress
ButallIneedisasimplechisquaretest
Youcan’tdefyus,weknowallaboutbias
WelearneditallduringMECORTIME.
Oh,Oh,Oh
MECORMECORTIME
OH,OH,OH
MECORMECORTIME
(TothetuneofBillyJoel’sTheLongestTime)
MECOR Türkiye 2015
Çok çalıştık
MECOR Türkiye 2015
çok sunum yaptık
MECOR Türkiye 2015
Çok tartıştık
MECOR Türkiye 2015
Çok yardımlaştık
MECOR Turkey 2015
Level 1: Araştırma Başlıkları
 Are treatment beliefs associated with adherence to long term
noninvasive mechanical ventilation in COPD?
 What is the difference in true positivity rate of COPD diagnosis
between secondary ad tertiary care?
 What is the prevalence and determinants of pneumoconiosis
risk in Turkish ceramic factory workers?
 What is the prevalence of influenza vaccination among elderly
attending the chest disease outpatient clinic and what is the
association with gender?
MECOR Turkey 2015
Level 2: Araştırma Başlıkları

Evaluation of coronary artery plaque volume in OSA
patients requiring nocturnal PAP treatment

Is there any new group in eosinophilic airway
disorders associated with chronic cough

Is Iron responsive protein 2 (IRP-2) associated with
frequent exacerbator phenotype in severe COPD
patients

Effect of Hemodialysis on IGRA Results in Renal
Transplantation Candidates

Is FVC associated with increased mortality within 28
days after ventriculer assit device operation?
MECOR Turkey 2015
Level 2: Araştırma Başlıkları


Prevalance of ACOS in primary care

Treatment of venous thromboembolism: Predictors of
adherence to guidelines by physicians in inpatient setting

Attitudes of pulmonary physicians towards influenza
vaccination in Turkey


microRNA profile of Obstructive Sleep Apnea
The relation between higher total IgE levels and
sensitization to staphylococcus aureus enterotoxins in
non-atopic patients
PatientsAssociation between Erectile Dysfunction and
COPD Assessment Test (CAT) in COPD
MECOR Turkey 2015
Level 3: Araştırma Başlıkları

The prognostic value of perineural in surgically
resected early-stage non small cell lung cancer.

Poor knowledge of asthma in a risk factor for reduced
asthma control

The association between obstructive sleep apnea
syndrome and vitamin D deficiency

Work related symptoms in adult patients with asthma
in Turkey

Malignant plural effusion with talk pleurodesis: is
small bore catheter hospital stay shorter than large
bore catheter
MECOR 2015
Global Course: Araştırma Başlıkları

The relation of biomass exposure to the burden of respiratory
symptoms, quality of life and lung function

The prevalence of and factors associated with tobacco
smoking behaviors among long distance drivers in Lagos
Nigeria

Prevalence of sleep disordered breathing and associated
factors in children living in urban and rural areas

Performance of rapid diagnostic test relative to microscopy in
detecting Plasmodium specie in children aged one to five
years in on an outpatient clinic in Nigeria

Predictors of high quality asthma care among physicians in
south west Nigeria
MECOR 2015
Global Course: Araştırma Başlıkları

Chinese herbs for acute asthma: a multi-center, randomized
double-blind placebo controlled trial

Prevalence of aspergillus hypersensitivity and ABPA in patients
with asthma


Impact of social support on TB outcome in Nigerian patients

Does eosinophilic COPD exacerbation have better outcome
than non-eosinophilic in the intensive are unit

Does PET-CT usage for staging cause delay in time to
treatment in patients with histologically proven lung cancer
Burden of cardiovascular abnormalities and associated factors
in HIV-infected adults in north-central Nigeria
Gelecek yıl görüşmek üzere!
“Improving global lung health through development of
local, country and regional lung disease research capacity”
Acknowledgements
The ATS MECOR Program is developed and implemented by
the American Thoracic Society (ATS)
MECOR Turkey 2015 is supported financially and in kind by:
 American Thoracic Society
 Turkish Thoracic Society
The American Thoracic Society acknowledges and thanks
Dr. Fusun Öner EYÜBOĞLU and her colleagues who administered and
organized MECOR Turkey 2015
Our sincere thanks to all who share the vision of and support the
ATS MECOR Program